Allstate Corp Makes New $1.73 Million Investment in HCA Healthcare, Inc. (NYSE:HCA)

Allstate Corp purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 5,751 shares of the company's stock, valued at approximately $1,726,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. D.A. Davidson & CO. lifted its holdings in HCA Healthcare by 61.3% during the 3rd quarter. D.A. Davidson & CO. now owns 4,042 shares of the company's stock valued at $1,643,000 after purchasing an additional 1,536 shares during the last quarter. Townsquare Capital LLC lifted its stake in shares of HCA Healthcare by 12.8% during the 3rd quarter. Townsquare Capital LLC now owns 2,687 shares of the company's stock worth $1,092,000 after buying an additional 305 shares during the last quarter. Glenmede Trust Co. NA raised its holdings in HCA Healthcare by 4.4% in the 3rd quarter. Glenmede Trust Co. NA now owns 3,022 shares of the company's stock valued at $1,228,000 after acquiring an additional 128 shares during the period. CreativeOne Wealth LLC grew its position in shares of HCA Healthcare by 253.9% in the third quarter. CreativeOne Wealth LLC now owns 3,189 shares of the company's stock valued at $1,296,000 after purchasing an additional 2,288 shares during the last quarter. Finally, Financial Counselors Inc. lifted its holdings in HCA Healthcare by 3.0% during the 3rd quarter. Financial Counselors Inc. now owns 1,551 shares of the company's stock worth $630,000 after purchasing an additional 45 shares during the last quarter. Institutional investors own 62.73% of the company's stock.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of NYSE HCA traded up $1.78 during mid-day trading on Thursday, hitting $348.81. 593,295 shares of the stock traded hands, compared to its average volume of 1,347,010. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97. The company has a market cap of $85.88 billion, a PE ratio of 15.88, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a 50 day simple moving average of $326.35 and a two-hundred day simple moving average of $340.30.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period last year, the firm posted $5.90 earnings per share. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.83%. This is an increase from HCA Healthcare's previous quarterly dividend of $0.66. The ex-dividend date was Monday, March 17th. HCA Healthcare's dividend payout ratio (DPR) is 13.11%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the company. Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an "outperform" rating for the company in a research report on Monday, January 27th. KeyCorp decreased their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating on the stock in a research report on Tuesday, January 7th. Truist Financial cut their price target on HCA Healthcare from $430.00 to $390.00 and set a "buy" rating for the company in a research note on Monday, January 6th. Morgan Stanley cut their target price on HCA Healthcare from $406.00 to $355.00 and set an "equal weight" rating for the company in a research report on Tuesday, December 17th. Finally, Bank of America cut their price objective on shares of HCA Healthcare from $380.00 to $370.00 and set a "buy" rating for the company in a research report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of "Moderate Buy" and an average target price of $385.67.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.